Discontinued — last reported Q3 '25
Viatris Intangibles (Net) decreased by 4.3% to $13.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.1%, from $15.86B to $13.78B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -13.5% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.78B | $26.91B | $26.13B | $25.21B | $24.06B | $22.97B | $22.61B | $22.37B | $21.75B | $20.96B | $19.18B | $18.14B | $17.53B | $17.09B | $17.07B | $15.86B | $15.52B | $14.95B | $14.40B | $13.78B |
| QoQ Change | — | -3.2% | -2.9% | -3.6% | -4.6% | -4.5% | -1.6% | -1.0% | -2.8% | -3.6% | -8.5% | -5.4% | -3.4% | -2.5% | -0.1% | -7.1% | -2.1% | -3.7% | -3.7% | -4.3% |
| YoY Change | — | — | — | — | -13.4% | -14.6% | -13.5% | -11.2% | -9.6% | -8.7% | -15.2% | -18.9% | -19.4% | -18.5% | -11.0% | -12.6% | -11.4% | -12.5% | -15.7% | -13.1% |
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Greater China | $6.12B | $5.64B | $5.22B | $4.79B | $4.36B |
| Emerging Markets | $4.16B | $3.39B | $3.04B | $2.74B | $2.46B |
| JANZ | $1.50B | $1.33B | — | $1.04B | $946.20M |
| Total | $26.13B | $22.61B | $19.18B | $17.07B | $14.40B |